The effectiveness of convalescent plasma in the treatment of COVID-19: a systematic review
DOI:
https://doi.org/10.33448/rsd-v11i4.26877Keywords:
COVID-19; Convalescent plasma; SARS-CoV-2.Abstract
The aim of this review was to analyze the therapeutic effectiveness of convalescent plasma used in patients with diagnosis confirmed of COVID-19. Methods: This is a systematic literature review propose in the Cochrane Collaboration Manual, with the elaboration of the PICO strategy, in which the Pubmed/Medline, BVS, Embase, CINAHL, LILACS, Cochrane and Google Scholar databases were used. Randomized clinical trials and systematic reviews were selected. We found 1249 articles, applying the inclusion and exclusion criteria, 8 articles were selected. AMSTAR-2 was used to assess the risk of bias and the quality of the evidence from the studies included in the systematic review was evaluated by the Grading of Recommendations Assessment Development and Evaluation (GRADE). Results: Regarding the results, studies with a low level of Oxford evidence predominated (75%). Four studies (50%) showed evidence level 2B. However, one response to this analysis was the low quality of the evidence and little confidence in the results of the studies. The qualitative synthesis revealed that although it was able to reduce the viral load, the use of convalescent plasma does not contribute in isolation to the reduction of the load. Conclusion: It is concluded that convalescent plasma is effective for reducing viral load and that many studies are still lacking, particularly economic analysis of effectiveness, as it is a cheap technology with potential for incorporation into the SUS.
References
Aviani, J. K., Halim, D., Soeroto, A. Y., Achmad, T. H. & Djuwantono, T. (2021). Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: A systematic review and meta-analysis based on recent studies and previous respiratory pandemics. Reviews in medical virology, 31 (6), e2225. https://doi.org/10.1002/rmv.2225
Bar, K. J., Shaw, P. A., Choi, G. H., Aqui, N., Fesnak, A., Yang, J. B., Soto-Calderon, H., Grajales, L., Starr, J., Andronov, M., Mastellone, M., Amonu, C., Feret, G., DeMarshall, M., Buchanan, M., Caturla, M., Gordon, J., Wanicur, A., Monroy, M. A., … Tebas, P. (2021). A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia. The Journal of clinical investigation, 131 (24), e155114. https://doi.org/10.1172/JCI155114
Brasil. (16 de fevereiro 2022). Painel –Coronavírus. In Coronavírus/Brasil. Ministério da Saúde. https://covid.saude.gov.br/
Brasil. (2020). Portaria nº 454, de 20 de março de 2020. Declara, em todo o território nacional, o estado de transmissão comunitária do coronavírus (covid-19). Ministério da Saúde.
Brasil. (2012). Diretrizes metodológicas: elaboração de revisão sistemática e metanálise de ensaios clínicos randomizados. Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Ciência e Tecnologia.
BRASI (2020). Nota Técnica Nº 19/2020-SEI/GSTCO/DIRE1/ANVISA. Brasília, DF: Agência Nacional de Vigilância Sanitária
Brasil. (2021). Diretrizes metodológicas: elaboração de revisão sistemática e meta-análise de ensaios clínicos randomizados. Ministério da Saúde, Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde, Departamento de Gestão e Incorporação de Tecnologias em Saúde.
Casadevall, A., Henderson, J. P, Joyner, M. J & Pirofski, L-A. (2021). SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities. Journal of Clinical Investigation, 131(7). https://doi.org/10.1172/JCI148832.
Centre for reviews and dissemination. (2009). Systematic Reviews: CRD’s: guidance for undertaking reviews in health care. York Publishing Services Ltd.
Galvão, T. F. & Pereira, M. G. (2014). Revisões sistemáticas da literatura: passos para sua elaboração. Epidemiologia e Serviços de Saúde. 23 (1), 183–184.
Higgins, J. P. T., Savović, J., Page, M. J., Elbers, R. G. & Sterne, J. A. C. (2021). Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins, J. P. T. & Thomas, J. (Ed.). Cochrane Handbook for Systematic Reviews of Interventions version 6.2. Cochrane.
Korley, F. K., Durkalski-Mauldin, V., Yeatts, S. D., Schulman, K., Davenport, R. D., Dumont, L. J., Kassar, N. E., Foster, L. D., Hah, J. M., Jaiswal, S., Kaplan, A., Lowell, E., McDyer, J. F., Quinn, J., Triulzi, D. J., Van Huysen, C., Stevenson, V. L.W., Yadav, K., Jones, C. W., … Callaway, C. W. (2021). Early Convalescent Plasma for High-Risk Outpatients with Covid-19. New England Journal of Medicine, 385 (21), 1951–1960.
Kutner, J. M. (2022) Uso de plasma convalescente em doentes da COVID-19. Sociedade Beneficente Israelita Brasileira Albert Einstein. https://ensino.einstein.br/uso_de_plasma_convalescente_em_doentes_da_c_p3242/p
Li, L., Zhang, W., Hu, Y., Tong, X., MD, Zheng, S., Yang, J., Kong, Y., Ren, L., Wei, Q., Mei, H., Hu, C., Tao, C., Yang, R., Wang, J., Yu, Y., Guo, Y., Wu, X., Xu, Z., Zeng, L., ... Liu, Z. (2020). Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. JAMA, 324 (5), 460-470.
Libster, R., Pérez Marc, G., Wappner, D., Coviello, S., Bianchi, A., Braem, V., Esteban, I., Caballero, M. T., Wood, C., Berrueta, M., Rondan, A., Lescano, G., Cruz, P., Ritou, Y., Viña, V. F., Paggi, D. Á., Esperante, S., Ferreti, A., ... Polack, F. P. (2021). Fundación INFANT–COVID-19 Group. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults. N Engl J Med. 384(7), 610-618.
Ortigoza, M. B., Yoon, H., Goldfeld, K. S., Troxel, A. B., Daily, J. P., Wu, Y., Li, Y. Wu, D., Cobb, G. F., Baptiste, G., O’Keeffe, M., Corpuz, M. O., Ostrosky-Zeichner, L., Amin, A., Zacharioudakis, I. M., Jayaweera, D. T., Wu, Y., Philley, J. V., Devine, M. S., … CONTAIN COVID-19 Consortium for the CONTAIN COVID-19 Study Group. (2022). Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients. JAMA, 182 (2), 115-126.
Ouzzani, M., Hammady, H., Fedorowicz, Z. & Elmagarmid, A. (2016). Rayyan - a web and mobile app for systematic reviews. Systematic Reviews, 5 (1), 210. https://doi.org/10.1186/s13643-016-0384-4
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. British Medical Journal, 372 (71), 1-9. https://doi.org/10.1136/bmj.n71
Rasheed, A. M., Fatak, D. F., Hashim, A. H., Maulood, M. F., Kabah, K. K., Almusawi, Y. A. & Abdulamir, A. S. (2020). The therapeutic effectiveness of Convalescent plasma therapy on treating COVID-19 patients residing in respiratory care units in Baghdad, Iraq 2020. MedRxiv. https://doi.org/10.1101/2020.06.24.20121905
Santos, C. M., Pimenta, C. A. & Nobre, M. R. (2007). The PICO strategy for the research question construction and evidence search. Revista Latino-Americana de Enfermagem, 15 (3), 508-51. http://dx.doi.org/10.1590/S0104-11692007000300023
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E. & Henry, D. A. (2017). AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. British Medical Journal, 358, j4008.
Simonovich, V. A., Burgos Pratx, L. D., Scibona, P., Beruto, M. V., Vallone, M. G., Vázquez, C., Savoy, N., Giunta, D. H., Pérez, L. G., Sánchez, M. L., Gamarnik, A. V., Ojeda, D. S., Santoro, D. M., Camino, P. J., Antelo, S., Rainero, K., Vidiella, G. P., Miyazaki, E. A., Cornistein, W., ... Belloso, W. H. (2020). PlasmAr Study Group. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia. New England Journal of Medicine, 384 (7), 619-629.
Siddaway, A. P., Wood, A. M. & Hedges, L. V. (2019). How to do a systematic review: a best practice guide for conducting and reporting narrative reviews, meta-analyses, and meta-syntheses. Annual Review of Psychology, 70, 747-770. https://doi.org/10.1146/annurev-psych-010418-102803
Sullivan, H. C. & Roback, J. D. (2020). Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic. Transfusion Medicine Reviews, 34, 145-150.
World Health Organization. (26 de abril de 2020). Coronavirus Disease 2019 (COVID-19). In WHO, Situation Report – 97. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200426-sitrep-97-covid-19.pdf
World Health Organization. (11 de março de 2021). Coronavírus Pandemic. In. WHO, Situation Report – 51. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57
Zhang, X., Xi, L., Pang, F., Du, Y., Yuan, Q., Shi, M., Liu, J., Ma, H. & Li, B. (2020). Convalescent plasma in the treatment of severe covid-19: a systematic review and meta-analysis. Iranian journal of public health, 49(11), 2022–2031, 2020. https://doi.org/10.18502/ijph.v49i11.4716
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Marcia Rodrigues dos Santos; Adriana Carla Bridi; Thiago Quinellato Louro; Márglory Fraga de Carvalho; Tatiana Santos de Carvalho; Roberto Carlos Lyra da Silva; Carlos Roberto Lyra da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
